These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 36035077

  • 1. A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV.
    Sarma H, Sastry GN.
    ACS Omega; 2022 Aug 30; 7(34):30003-30022. PubMed ID: 36035077
    [Abstract] [Full Text] [Related]

  • 2. Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity.
    Smith EC, Case JB, Blanc H, Isakov O, Shomron N, Vignuzzi M, Denison MR.
    J Virol; 2015 Jun 30; 89(12):6418-26. PubMed ID: 25855750
    [Abstract] [Full Text] [Related]

  • 3. The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity.
    Grimes SL, Heaton BE, Anderson ML, Burke K, Stevens L, Lu X, Heaton NS, Denison MR, Anderson-Daniels J.
    bioRxiv; 2024 Sep 26. PubMed ID: 39386528
    [Abstract] [Full Text] [Related]

  • 4. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.
    Ogando NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, Posthuma CC, Snijder EJ.
    J Virol; 2020 Nov 09; 94(23):. PubMed ID: 32938769
    [Abstract] [Full Text] [Related]

  • 5. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
    Saramago M, Bárria C, Costa VG, Souza CS, Viegas SC, Domingues S, Lousa D, Soares CM, Arraiano CM, Matos RG.
    FEBS J; 2021 Sep 09; 288(17):5130-5147. PubMed ID: 33705595
    [Abstract] [Full Text] [Related]

  • 6. Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors.
    Riccio AA, Sullivan ED, Copeland WC.
    J Biol Chem; 2022 Jan 09; 298(1):101518. PubMed ID: 34942146
    [Abstract] [Full Text] [Related]

  • 7. Analysis of critical protein-protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides.
    Arabi-Jeshvaghani F, Javadi-Zarnaghi F, Ganjalikhany MR.
    Sci Rep; 2023 Jan 07; 13(1):350. PubMed ID: 36611052
    [Abstract] [Full Text] [Related]

  • 8. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.
    Ma Z, Pourfarjam Y, Kim IK.
    Protein Expr Purif; 2021 Sep 07; 185():105894. PubMed ID: 33933612
    [Abstract] [Full Text] [Related]

  • 9. Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN.
    Moeller NH, Shi K, Demir Ö, Belica C, Banerjee S, Yin L, Durfee C, Amaro RE, Aihara H.
    Proc Natl Acad Sci U S A; 2022 Mar 01; 119(9):. PubMed ID: 35165203
    [Abstract] [Full Text] [Related]

  • 10. Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity.
    Lin S, Chen H, Chen Z, Yang F, Ye F, Zheng Y, Yang J, Lin X, Sun H, Wang L, Wen A, Dong H, Xiao Q, Deng D, Cao Y, Lu G.
    Nucleic Acids Res; 2021 May 21; 49(9):5382-5392. PubMed ID: 33956156
    [Abstract] [Full Text] [Related]

  • 11. Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN.
    Moeller NH, Shi K, Demir Ö, Banerjee S, Yin L, Belica C, Durfee C, Amaro RE, Aihara H.
    bioRxiv; 2021 Apr 04. PubMed ID: 33821277
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
    Baddock HT, Brolih S, Yosaatmadja Y, Ratnaweera M, Bielinski M, Swift LP, Cruz-Migoni A, Fan H, Keown JR, Walker AP, Morris GM, Grimes JM, Fodor E, Schofield CJ, Gileadi O, McHugh PJ.
    Nucleic Acids Res; 2022 Feb 22; 50(3):1484-1500. PubMed ID: 35037045
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity.
    Czarna A, Plewka J, Kresik L, Matsuda A, Karim A, Robinson C, O'Byrne S, Cunningham F, Georgiou I, Wilk P, Pachota M, Popowicz G, Wyatt PG, Dubin G, Pyrć K.
    Structure; 2022 Aug 04; 30(8):1050-1054.e2. PubMed ID: 35609600
    [Abstract] [Full Text] [Related]

  • 15. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes.
    Bouvet M, Lugari A, Posthuma CC, Zevenhoven JC, Bernard S, Betzi S, Imbert I, Canard B, Guillemot JC, Lécine P, Pfefferle S, Drosten C, Snijder EJ, Decroly E, Morelli X.
    J Biol Chem; 2014 Sep 12; 289(37):25783-96. PubMed ID: 25074927
    [Abstract] [Full Text] [Related]

  • 16. New insights into complex formation by SARS-CoV-2 nsp10 and nsp14.
    Sele C, Krupinska E, Andersson Rasmussen A, Ekström S, Hultgren L, Lou J, Kozielski F, Fisher SZ, Knecht W.
    Nucleosides Nucleotides Nucleic Acids; 2024 Sep 12; 43(8):798-812. PubMed ID: 38422227
    [Abstract] [Full Text] [Related]

  • 17. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex.
    Ma Y, Wu L, Shaw N, Gao Y, Wang J, Sun Y, Lou Z, Yan L, Zhang R, Rao Z.
    Proc Natl Acad Sci U S A; 2015 Jul 28; 112(30):9436-41. PubMed ID: 26159422
    [Abstract] [Full Text] [Related]

  • 18. Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16.
    Kozielski F, Sele C, Talibov VO, Lou J, Dong D, Wang Q, Shi X, Nyblom M, Rogstam A, Krojer T, Fisher Z, Knecht W.
    RSC Chem Biol; 2022 Jan 05; 3(1):44-55. PubMed ID: 35128408
    [Abstract] [Full Text] [Related]

  • 19. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
    Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR.
    mBio; 2018 Mar 06; 9(2):. PubMed ID: 29511076
    [Abstract] [Full Text] [Related]

  • 20. Protein-protein interaction of RdRp with its co-factor NSP8 and NSP7 to decipher the interface hotspot residues for drug targeting: A comparison between SARS-CoV-2 and SARS-CoV.
    Sarma H, Jamir E, Sastry GN.
    J Mol Struct; 2022 Jun 05; 1257():132602. PubMed ID: 35153334
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.